简介
Professor Dr. Thomas Efferth
born June 23th, 1960, married
Education:
1980-1986 Study of Biology, Technical University Darmstadt, Germany
1990 PhD Thesis at the German Cancer Research Center, Heidelberg, Germany
1997 Habilitation (Postdoctorate Thesis), Technical University Aachen, Germany
Positions:
2005 Research group leader, German Cancer Research Center, Heidelberg, Germany
2007 Associate Professor (apl.), University of Heidelberg, Germany
2009 Full Professor, Chair of the Department of Pharmaceutical Biology, Institute of Pharmacy and
Biochemistry, Johannes Gutenberg University, Mainz, Germany
2021 Director, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz,
Germany
Honors:
1991 Ludolf Krehl-Award (1st place) of Southwest-German Society for Medicine
2006 Honorary professor at the Northeast Forestry University, Harbin, China
2006 Dr. Wilmar Schwabe Award conferred by the Society for Medical Plant Research in
Helsinki, Finland, August 30th 2006
2008 Citizen Medal (Bürgerplakette) of the City of Heidelberg, Germany
2010 Visiting professor at the Zhejiang Medical University, Hangzhou, China
2011 Award (1st place) of the Central European Society for Anticancer Drug Research (CESAR) for
translational research in the development of antitumoral agents
2015 Honorary professor at the Zhejiang Medical University, Hangzhou, China
2015 Visiting professor at the Zhejiang University for Science and Technology, Hangzhou, China
2015 “TheSCENTEDdrop” Award (1st place) for research on medicinal herbs and fragrant plants, Graz, Austria
2016 Appreciation Award, Salah Wanasi Foundation for Cancer Research and Control, Khartoum, Sudan
2017 Qihuang International Award, Chinese Society of Chinese Medicine
2018 Honorary adjunct professor, Chinese University of Hong Kong
2018 Full member, World Academy of Sciences (WAS)
2019 Honorary professor, Hong Kong Baptist University
2020 Top 2% in the Stanford University worldwide citation ranking 2019 of all scientists and scientific
disciplines (Ioannidis et al., PLoS Biol 2020;18:e3000918;
https://data.mendeley.com/datasets/btchxktzyw/2)
2021 High Impact Paper Award of the journal “Engineering” (edited by Chinese Academy of Engineering) for
the fifth-most cited paper in 2019 (top 3.5%)
2021 SFE Outstanding International Ethnopharmacologist Award
Teaching: Pharmaceutical Biology, Molecular Pharmacology and Toxicology, Biogenic Drugs, Molecular Medicine
Research:
• Transcriptomic-based network pharmacology of synthetic and biogenic drugs and bioinformatic pharmacology in basic
and translational research to identify novel predictive and prognostic markers for personalized medicine
• Mode of action and toxicological analyses of synthetic and biogenic drugs to characterize their safety and efficacy
• Artesunate for cancer therapy (basic and translational research including clinical trials)
Publications:
• Hirsch (h)-factor: 94; total number of citations: 48,000+ (according to Google Scholar)
• 720+ PubMed-listed (830+ Scopus-listed) publications (https://pubmed.ncbi.nlm.nih.gov/?term=Efferth)
• 43 book chapters, four books
• 8 patents (US60/619,829; US10/748,713, EP1 550 731 A1, EP8211231.8, ES200401396, 20 2014 006 418.0;
2015101808; 2015101721)
• 320 lectures and 200+ posters at international meetings and congresses
Selected original and review papers:
• Effeth T, Oesch F. Medicinal Research Reviews 2021 (online ahead of print) (IF: 12.9)
• Kadioglu, O, …. Efferth T. Journal of the American Academy of Dermatology 2021;84:1086-1089. (IF: 11.5)
• Padra et al., Seminars in Cancer Biology 2021;73:310-320. (IF:11.1)
• Efferth T, Oesch F. Seminars in Cancer Biology 2021;68:143-163. (11.1)
• Lu X, Efferth T. Seminars in Cancer Biology 2021;68:291-312. (IF: 11.1)
• Panossian AG, Efferth T, et al. Medicinal Research Reviews 2021;41:630-703. (IF: 12.9)
• Atanasov AG et al. Nature Reviews Drug Discovery 2021;20:200-216. (IF: 84.7).
• Klionsky DJ et al. Autophagy 2021;17:1-382. IF: 16.0).
• Elbadawi M, Efferth T. Lancet Respiratory Medicine 2020;S2213-2600:30238-1. (IF: 30.7)
• Efferth T et al. Biotechnology Advances 2020;38:107342. (IF:14.2)
• Efferth T, Oesch F. Seminars in Cancer Biology 2020; doi: 10.1016/j.semcancer.2020.01.015 8 (IF: 11.1)
• Abdelfatah S, …. Efferth T. Acta Pharmaceutica Sinica B 2019;9:1021-1034. (IF: 11.4)
• Efferth T. Biotechnology Advances 2018 36:1730-1737. (IF: 14.2)
• Krieger J et al. Angewandte Chemie International Edition in English 2018;57:8293-8296. (IF: 15.3)
• Efferth T, Paul NW. Lancet Planet Health 2017;1:e301-e303. (IF: 19.1)
• Efferth T. Seminars in Cancer Biology 2017;46:65-83. (IF: 11.1)
• Li PCH, …. Efferth T. Cancer Research 2008;68:4347-4351. (IF: 12.7)
• Efferth T et al. Clinical Cancer Research 2008;14:2405-2412. (IF: 12.5)
• Efferth T et al. Trends in Molecular Medicine 2007;13:353-361. (IF: 11.9)
• Steinbach D, …. Efferth T. Clinical Cancer Research 2006;12:4357-4363. (IF: 12.5).
• Efferth T et al.
